LMNL logo

Liminal BioSciences (LMNL) Total Assets

Annual Total Assets

$37.18 M
-$61.68 M-62.39%

December 31, 2022


Summary


Performance

LMNL Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherLMNLbalance sheetmetrics:

Quarterly Total Assets

$23.99 M
-$4.96 M-17.13%

June 30, 2023


Summary


Performance

LMNL Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherLMNLbalance sheetmetrics:

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

LMNL Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-62.4%-56.4%
3 y3 years-70.6%-70.5%
5 y5 years-83.5%-88.0%

LMNL Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-62.4%at low-75.7%at low
5 y5-year-70.6%at low-81.0%at low
alltimeall time-83.5%-86.1%-89.8%-83.2%

Liminal BioSciences Total Assets History

DateAnnualQuarterly
Jun 2023
-
$23.99 M(-17.1%)
Mar 2023
-
$28.96 M(-22.1%)
Dec 2022
$37.18 M(-62.4%)
$37.18 M(-5.7%)
Sep 2022
-
$39.42 M(-28.3%)
Jun 2022
-
$55.00 M(-11.0%)
Mar 2022
-
$61.82 M(-37.5%)
Dec 2021
$98.86 M(+7.0%)
$98.86 M(-14.5%)
Sep 2021
-
$115.60 M(+80.9%)
Jun 2021
-
$63.89 M(-15.1%)
Mar 2021
-
$75.22 M(-18.6%)
Dec 2020
$92.37 M(-26.9%)
$92.37 M(+2.5%)
Sep 2020
-
$90.13 M(+10.8%)
Jun 2020
-
$81.33 M(-14.2%)
Mar 2020
-
$94.82 M(-25.0%)
Dec 2019
$126.39 M(+67.3%)
$126.39 M(-8.3%)
Sep 2019
-
$137.77 M(-12.1%)
Jun 2019
-
$156.73 M(+48.8%)
Mar 2019
-
$105.33 M(+39.4%)
Dec 2018
$75.54 M(-66.5%)
$75.54 M(-63.3%)
Sep 2018
-
$205.75 M(+2.4%)
Jun 2018
-
$200.84 M(-7.9%)
Mar 2018
-
$218.15 M(-3.4%)
Dec 2017
$225.74 M(+14.7%)
$225.74 M(-4.5%)
Sep 2017
-
$236.40 M(+22.1%)
Jun 2017
-
$193.60 M(+2.4%)
Mar 2017
-
$189.09 M(-3.9%)
Dec 2016
$196.77 M(+26.8%)
$196.77 M(+7.2%)
Sep 2016
-
$183.57 M(-8.8%)
Jun 2016
-
$201.30 M(+14.8%)
Mar 2016
-
$175.33 M(+13.0%)
Dec 2015
$155.14 M(-11.5%)
$155.14 M(-7.7%)
Sep 2015
-
$168.06 M(-11.6%)
Jun 2015
-
$190.07 M(+23.9%)
Mar 2015
-
$153.40 M(-12.5%)
Dec 2014
$175.25 M(+274.2%)
$175.25 M(+41.8%)
Sep 2014
-
$123.60 M(+1.5%)
Jun 2014
-
$121.72 M(+196.5%)
Mar 2014
-
$41.05 M(-12.4%)
Dec 2013
$46.84 M(+102.7%)
$46.84 M(+76.2%)
Sep 2013
-
$26.58 M(+40.0%)
Jun 2013
-
$18.99 M(-4.3%)
Mar 2013
-
$19.85 M(-14.1%)
Dec 2012
$23.11 M(+171.4%)
$23.11 M(+45.7%)
Sep 2012
-
$15.86 M(+17.7%)
Jun 2012
-
$13.48 M(+46.8%)
Mar 2012
-
$9.18 M(+7.8%)
Dec 2011
$8.51 M(-0.9%)
$8.51 M(-6.3%)
Sep 2011
-
$9.09 M(+2.5%)
Jun 2011
-
$8.87 M(+4.7%)
Mar 2011
-
$8.47 M(-1.4%)
Dec 2010
$8.59 M
$8.59 M(-14.7%)
Sep 2010
-
$10.07 M(-26.9%)
DateAnnualQuarterly
Jun 2010
-
$13.77 M(-27.1%)
Mar 2010
-
$18.87 M(+79.4%)
Dec 2009
$10.52 M(-32.3%)
$10.52 M(-10.6%)
Sep 2009
-
$11.77 M(-14.5%)
Jun 2009
-
$13.76 M(-2.9%)
Mar 2009
-
$14.17 M(-8.8%)
Dec 2008
$15.54 M(-20.0%)
$15.54 M(-25.1%)
Sep 2008
-
$20.76 M(+6.8%)
Jun 2008
-
$19.43 M(+13.9%)
Mar 2008
-
$17.07 M(-12.1%)
Dec 2007
$19.42 M(-44.4%)
$19.42 M(-21.3%)
Sep 2007
-
$24.69 M(+2.1%)
Jun 2007
-
$24.17 M(-11.9%)
Mar 2007
-
$27.45 M(-21.4%)
Dec 2006
$34.92 M(+36.2%)
$34.92 M(+62.5%)
Sep 2006
-
$21.49 M(-23.1%)
Jun 2006
-
$27.94 M(+25.9%)
Mar 2006
-
$22.20 M(-13.4%)
Dec 2005
$25.64 M(+3.7%)
$25.64 M(+4.1%)
Sep 2005
-
$24.63 M(-13.4%)
Jun 2005
-
$28.43 M(+19.5%)
Mar 2005
-
$23.80 M(-3.7%)
Dec 2004
$24.72 M(-24.7%)
$24.72 M(-0.5%)
Sep 2004
-
$24.83 M(-8.7%)
Jun 2004
-
$27.21 M(-9.2%)
Mar 2004
-
$29.97 M(-8.7%)
Dec 2003
$32.82 M(+31.3%)
$32.82 M(+70.1%)
Sep 2003
-
$19.29 M(-15.4%)
Jun 2003
-
$22.81 M(-5.2%)
Mar 2003
-
$24.07 M(-3.7%)
Dec 2002
$25.00 M(+64.3%)
$25.00 M(-6.1%)
Sep 2002
-
$26.63 M(-10.2%)
Jun 2002
-
$29.66 M(+95.3%)
Mar 2002
-
$15.18 M(-0.2%)
Dec 2001
$15.22 M(+61.0%)
$15.22 M(+12.3%)
Sep 2001
-
$13.55 M(+72.9%)
Jun 2001
-
$7.84 M(+0.5%)
Mar 2001
-
$7.80 M(-17.5%)
Dec 2000
$9.45 M(+83.3%)
$9.45 M(-11.7%)
Sep 2000
-
$10.71 M(+78.3%)
Jun 2000
-
$6.01 M(-13.6%)
Mar 2000
-
$6.95 M(+34.8%)
Dec 1999
$5.16 M(-78.1%)
$5.16 M(+28.3%)
Sep 1999
-
$4.02 M(-85.6%)
Jun 1999
-
$27.88 M(+19.2%)
Mar 1999
-
$23.39 M(-0.5%)
Dec 1998
$23.51 M(+168.4%)
$23.51 M(+20.7%)
Sep 1998
-
$19.49 M(+75.3%)
Jun 1998
-
$11.12 M(+13.8%)
Mar 1998
-
$9.76 M(+22.8%)
Dec 1997
-
$7.95 M
Sep 1997
$8.76 M
-

FAQ

  • What is Liminal BioSciences annual total assets?
  • What is the all time high annual total assets for Liminal BioSciences?
  • What is Liminal BioSciences annual total assets year-on-year change?
  • What is Liminal BioSciences quarterly total assets?
  • What is the all time high quarterly total assets for Liminal BioSciences?
  • What is Liminal BioSciences quarterly total assets year-on-year change?

What is Liminal BioSciences annual total assets?

The current annual total assets of LMNL is $37.18 M

What is the all time high annual total assets for Liminal BioSciences?

Liminal BioSciences all-time high annual total assets is $225.74 M

What is Liminal BioSciences annual total assets year-on-year change?

Over the past year, LMNL annual total assets has changed by -$61.68 M (-62.39%)

What is Liminal BioSciences quarterly total assets?

The current quarterly total assets of LMNL is $23.99 M

What is the all time high quarterly total assets for Liminal BioSciences?

Liminal BioSciences all-time high quarterly total assets is $236.40 M

What is Liminal BioSciences quarterly total assets year-on-year change?

Over the past year, LMNL quarterly total assets has changed by -$31.01 M (-56.38%)